Skip to main content

HA656

Product Details
WHO Product ID
HA656
Status
Prequalified
INN, dosage form and strength
Lamivudine/Zidovudine Tablet, Film-coated 150mg/300mg
Date of prequalification
Basis of listing
Prequalification - Full
Therapeutic area
HIV/AIDS
Type
Finished Pharmaceutical Product
Dosage form
Tablet, Film-coated
Applicant organization
Anhui Biochem Bio-Pharmaceutical Co Ltd
30 Hongfeng Road, Hi-Tech Development Zone
Hefei City,
Anhui
230088
China
Packaging details and storage conditions
Packaging Type
Bottle, HDPE
Configuration
60
Shelf life (months)
36
Storage conditions
Do not store above 30°C, store in the original container, protect from light
API Manufacturing Site(s)
By Organization
By Active Ingredient
Anhui Biochem Pharmaceutical Co Ltd
Zone B, Innovation Avenue, Taihe Industrial Park
Anhui
China
Lamivudine, Zidovudine
FPP Manufacturing Site(s)
Anhui Biochem Bio-Pharmaceutical Co Ltd
30 Hongfeng Road, Hi-Tech Development Zone
Hefei City,
Anhui
230088
China
WHO Public Assessment Reports


Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - WHO-PQ recommended patient information leaflet*
Part 4 - WHO-PQ recommended summary of product characteristics*
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

* This summary of product characteristics/patient information leaflet focus on uses of the medicine covered by WHO Prequalification Team - Medicines. The recommendations for use are based on WHO guidelines and on information from stringent regulatory authorities (term to be revised). The medicine may be authorised for additional or different uses by national medicines regulatory authorities. 

Part 1 , Part 2 , Part 3 , HA656part4v2.pdf , Part 5 , Part 6 , Part 7 , Part 8

.